Study of Advanced Integrative Oncology Treatment in Adults and Children With Cancer Tracking Survival and Treatment Outcomes Over Five Years

What this Trial Is About

Researchers are studying patients with cancer who receive care at the AIMS Institute to understand disease-free survival in early stage cancer and three-year overall survival in advanced cancer. This observational study focuses on patients treated with Advanced Integrative Oncology AIO, which combines naturopathic oncology care with conventional cancer treatments. The study aims to evaluate clinical outcomes associated with these integrative therapies, especially in both adult and pediatric cancer patients. Participants receive care that includes nutritional and botanical medicine integrated with their usual cancer treatments, provided by naturopathic doctors experienced in oncology. The study collects data prospectively in a consecutive case series format without altering participants standard medical care. This approach helps answer whether exposure to AIO services improves clinical outcomes for cancer patients. Throughout the study, researchers collect medical records and treatment information to analyze survival outcomes over five years. Both adults and children with confirmed cancer diagnoses who consent to participate are followed to assess their disease progress and treatment effects. The study monitors survival and treatment correlations while participants continue their regular oncology care, with a planned follow-up lasting at least five years.

AIMS Cancer Outcomes Study